Compounds > 6-methylene-4-pregnene-3,20-dione
Page last updated: 2024-09-03

6-methylene-4-pregnene-3,20-dione and Experimental Neoplasms

6-methylene-4-pregnene-3,20-dione has been researched along with Experimental Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Petrow, V1
Akimoto, S; Hayata, I; Ichikawa, T; Petrow, V; Shimazaki, J; Yazawa, S; Zama, S1

Reviews

1 review(s) available for 6-methylene-4-pregnene-3,20-dione and Experimental Neoplasms

ArticleYear
The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications.
    The Prostate, 1986, Volume: 9, Issue:4

    Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Adenocarcinoma; Animals; Dihydrotestosterone; Humans; Male; Neoplasms, Experimental; Neoplasms, Hormone-Dependent; Progesterone; Prostate; Prostatic Neoplasms; Rats; Testosterone

1986

Other Studies

1 other study(ies) available for 6-methylene-4-pregnene-3,20-dione and Experimental Neoplasms

ArticleYear
Androgen receptor, testosterone uptake and karyotype in androgen-dependent mouse tumor (SC 115) and its androgen-independent subline (CS 2).
    Endocrinologia japonica, 1987, Volume: 34, Issue:2

    Topics: Animals; Cell Nucleus; Cytosol; Karyotyping; Male; Mice; Neoplasms, Experimental; Neoplasms, Hormone-Dependent; Progesterone; Receptors, Androgen; Testosterone

1987